A detailed history of Cresset Asset Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 5,079 shares of NTRA stock, worth $645,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,079
Previous 5,563 8.7%
Holding current value
$645,540
Previous $508,000 8.27%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $41,275 - $54,498
-484 Reduced 8.7%
5,079 $550,000
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $329,385 - $516,802
5,563 New
5,563 $508,000
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $206,681 - $242,152
4,390 New
4,390 $213,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.